CAGRI

Cagri is a dual-compound research formulation combining CJC-1295, a long-acting growth hormone–releasing hormone analog, with Ipamorelin, a selective growth hormone stimulator. This blend supports endogenous growth hormone signaling, enabling the study of natural hormone regulation without administering external GH.

How It Works:

• CJC-1295: Facilitates prolonged stimulation of pituitary growth hormone release, making it valuable for research on metabolism, cellular regeneration, and long-term recovery signaling.
• Ipamorelin: Encourages pulse-like growth hormone release that mirrors natural physiological patterns, with minimal effects on stress hormones such as cortisol or prolactin.
• Synergistic Interaction: When combined, these compounds are studied for their complementary ability to enhance GH and IGF-1 signaling in a rhythmic, physiologically consistent manner, supporting research on sleep quality, recovery efficiency, and lean tissue development.

Potential Research Uses:

• Examination of sleep cycle depth and recovery-associated signaling patterns
• Analysis of musculoskeletal repair, connective tissue response, and joint-support mechanisms
• Investigation into cellular longevity, regeneration pathways, and age-related biological processes

Supplied by Nuera for research only. Not for human or animal use. Not evaluated by the FDA.